RNAi mediated MMP-1 silencing inhibits human chondrosarcoma invasion

J Orthop Res. 2005 Nov;23(6):1467-74. doi: 10.1016/j.orthres.2005.04.004.1100230633. Epub 2005 May 31.

Abstract

Previous work indicates that matrix metalloproteinase-1 (MMP-1) gene expression is a prognostic factor for local recurrence and metastasis in human chondrosarcoma. The current study evaluates the effects of MMP-1 knock-down via RNA interference on chondrosarcoma metastasis in vitro. Of nine siRNA oligos tested, one showed a 90% inhibitory effect on MMP-1 gene expression. Stable attenuation of MMP-1 in chondrosarcoma cells was achieved by using a plasmid vector-based siRNA system. Pronounced MMP-1 activity suppression was accompanied by marked inhibition of tumor cell invasion. Cells in which MMP-1 has been stably silenced are useful tools to elucidate the mechanism of MMP-1 mediated tumor metastasis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bone Neoplasms / pathology
  • Bone Neoplasms / therapy*
  • Cell Line
  • Chondrosarcoma / pathology
  • Chondrosarcoma / therapy*
  • Gene Silencing
  • Humans
  • Matrix Metalloproteinase 1 / genetics
  • Matrix Metalloproteinase Inhibitors*
  • Neoplasm Invasiveness
  • Plasmids
  • RNA Interference
  • RNA, Messenger / analysis
  • RNA, Small Interfering / therapeutic use*

Substances

  • Matrix Metalloproteinase Inhibitors
  • RNA, Messenger
  • RNA, Small Interfering
  • Matrix Metalloproteinase 1